Primo Nutraceuticals Inc.
Primo Nutraceuticals Inc. (BUGVF) Revenue
Annual & quarterly revenue history · segment & region breakdown
BUGVF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsPrimo Nutraceuticals Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2019.
Revenue trend
2019 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2019-07-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Primo Nutraceuticals Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Primo Nutraceuticals Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.
Data sourced from Primo Nutraceuticals Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BUGVF revenue · 4 questionsBUGVF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2019.
▸ Source: FMP · Primo Nutraceuticals Inc. SEC filings · GAAP · Primo Nutraceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026